2021
Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue® to the Montreal Cognitive Assessment
Rose A, Gilbertson A, Cottrell C, Tampi R. Cognitive screening for adult psychiatric outpatients: Comparison of the Cognivue® to the Montreal Cognitive Assessment. World Journal Of Psychiatry 2021, 11: 265-270. PMID: 34327120, PMCID: PMC8311515, DOI: 10.5498/wjp.v11.i7.265.Peer-Reviewed Original ResearchCognitive screening toolCognitive impairmentMontreal Cognitive AssessmentCognitive AssessmentCognitive screeningNeurocognitive disordersAdult psychiatric outpatientsScreening toolPsychiatric outpatient settingsPsychiatric outpatientsIndividual subtestsDiagnosis patientsPatients' performanceCognitive declineOlder adultsHealthcare costsOutpatient settingImpairmentScreening deviceMoCAEmotional harmDisordersPatientsSubtestsPsychometrically
2016
Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses
Tampi RR, Tampi DJ, Balachandran S, Srinivasan S. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses. Therapeutic Advances In Chronic Disease 2016, 7: 229-245. PMID: 27583123, PMCID: PMC4994396, DOI: 10.1177/2040622316658463.Peer-Reviewed Original ResearchUse of antipsychoticsLewy body dementiaSystematic reviewAlzheimer's diseaseAdverse effectsDiscontinuation of antipsychoticsNonpharmacological management strategiesAdverse effect profileEfficacy of antipsychoticsEffect profileAntipsychotic useModest efficacyCochrane CollaborationAntipsychoticsSevere symptomsFollowing keywordsDementiaLiterature searchFinal analysisAdditional studiesOfficial English translationsPatientsDiseaseEnglish-language journalsBibliographic databasesThe Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks.
Zdanys KF, Carvalho AF, Tampi RR, Steffens DC. The Treatment of Behavioral and Psychological Symptoms of Dementia: Weighing Benefits and Risks. Current Alzheimer Research 2016, 13: 1124-33. PMID: 27160166, DOI: 10.2174/1567205013666160510121633.Peer-Reviewed Original ResearchConceptsPsychological symptomsAssessment of BPSDManagement of BPSDPharmacologic treatment strategiesTreatment of BehavioralSignificant adverse effectsAvailable medicationsTreatment strategiesCurrent evidencePharmacological approachesWeighing benefitsBPSDDementiaAged populationAdverse effectsMedicationsPatientsSymptomsAvailable literatureRiskCaregivers